Influence of Octreotide and Tamoxifen on Tumor Growth and Liver Metastasis in N-Nitrosobis(2-oxopropyl)amine-Induced Pancreatic Cancer in Syrian Hamsters
暂无分享,去创建一个
H. Guski | I. Schimke | C. Jacobi | H. Guski | F.A. Wenger | M. Kilian | I. Mautsch | C.A. Jacobi | I. Schimke | G.J. Saul | J.M. Müller | F. Wenger | M. Kilian | I. Mautsch | J. M. Müller | G. Saul
[1] A. Schally,et al. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[2] P. Malfertheiner,et al. Treatment of advanced pancreatic cancer with high-dose octreotide , 1993, International journal of pancreatology : official journal of the International Association of Pancreatology.
[3] A. Griesmacher,et al. Effects of reactive oxygen species on eicosanoid metabolism in human endothelial cells. , 1992, Prostaglandins.
[4] J. Laissue,et al. Multiple actions of somatostatin in neoplastic disease. , 1995, Trends in pharmacological sciences.
[5] D. Longnecker,et al. Effects of sex steroid hormones on pancreatic cancer in the rat , 1990, International journal of pancreatology : official journal of the International Association of Pancreatology.
[6] R. S. Kent,et al. Regulation of vascular prostaglandin synthesis by metabolites of arachidonic acid in perfused rabbit aorta. , 1983, The Journal of clinical investigation.
[7] M. L’Abbé,et al. Dietary (n-3) fatty acids affect rat heart, liver and aorta protective enzyme activities and lipid peroxidation. , 1991, The Journal of nutrition.
[8] Hallin Pa,et al. MODELS OF PANCREATIC CANCER , 1993 .
[9] H. Friess,et al. Low‐Dose Octreotide Treatment Is Not Effective in Patients with Advanced Pancreatic Cancer , 1993, Pancreas.
[10] Lamberts Sw,et al. Etoposide plus carboplatin or cisplatin in good-risk patients with germ cell tumors: a randomized comparison. , 1994 .
[11] E. Krenning,et al. The role of somatostatin analogs in the control of tumor growth. , 1994, Seminars in Oncology.
[12] A. Barkun,et al. Low dose octreotide and tamoxifen in the treatment of adenocarcinoma of the pancreas , 1995, Cancer.
[13] H. Friess,et al. Role of octreotide in the treatment of pancreatic cancer. , 1994, Digestion.
[14] R. Woutersen,et al. Histogenesis of early preneoplastic lesions induced byN-nitrosobis(2-oxopropyl)amine in exocrine pancreas of hamsters , 1989, International journal of pancreatology : official journal of the International Association of Pancreatology.
[15] P. Hall,et al. Models of pancreatic cancer. , 1993, Cancer surveys.
[16] D F Horrobin,et al. Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. , 1998, Critical reviews in oncology/hematology.
[17] A. Schally,et al. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters. , 1991, Cancer research.
[18] F. Boccardo,et al. Treatment of advanced pancreatic carcinoma with the somatostatin analogue BIM 23014. Preliminary results of a pilot study , 1992, Cancer.
[19] J. Klijn,et al. Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas. , 1988, Gastroenterology.
[20] A. Andrén-sandberg,et al. Sex hormones and pancreatic cancer. , 1990, Bailliere's clinical gastroenterology.
[21] A. Schally,et al. Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[22] O. M. Taylor,et al. Classical oestrogen receptor is not detectable in pancreatic adenocarcinoma. , 1992, British Journal of Cancer.
[23] A. Schally,et al. Effect of combination treatment with analogs of luteinizing hormone‐releasing hormone (LH‐RH) or somatostatin and 5‐fluorouracil on pancreatic cancer in hamsters , 1991, International journal of cancer.
[24] D. Jaeck,et al. Treatment of adenocarcinoma of the pancreas with somatostatin and gonadoliberin (luteinizing hormone-releasing hormone). The French Associations for Surgical Research. , 1992, American journal of surgery.
[25] A. Schally,et al. Mechanisms of Antineoplastic Action of Somatostatin Analogs , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.